SI-BONE Q2 revenue $40M (+20% YoY); raises 2024 guidance to $165-167M

SI-BONE, Inc.

2024-Q2 EPS reported -$0.48 revenue$77,836,000

Revenue $40.0M, up 20% YoY; U.S. revenue $37.8M (+21%). Net loss $8.9M ($0.22 loss per share) improved 20%.
Adjusted EBITDA loss $2.7M, improved 43% YoY; expects positive adjusted EBITDA in Q4 2024.
Raises 2024 revenue guidance to $165M-$167M (previous $164M-$166M), implying ~19-20% growth.
Elected Daniel Wolf to Board of Directors effective Aug 5, 2024; he is SVP Chief Strategy & M&A at Baxter.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Daniel Wolf

Director

SIBN · SI-BONE, Inc.

Effective: 2024-08-05
Filed: August 5, 2024, 7:59 PM ET

On August 4, 2024, the Company’s board of directors (“Board”) elected Daniel Wolf to serve as a director of the Company effective August 5, 2024, until his successor is elected and qualified, or sooner in the event of his death, resignation or removal.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel Wolf was elected as Director at SI-BONE, Inc..

Action: elected
Role: Director

Exact text from the filing

On August 4, 2024, the Company’s board of directors (“Board”) elected Daniel Wolf to serve as a director of the Company effective August 5, 2024, until his successor is elected and qualified, or sooner in the event of his death, resignation or removal.

View on SEC.gov

SI-BONE, Inc. filing history →

Source: SEC EDGAR

accession 0001459839-24-000061

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.